| Dr Mark Anthony Lomibao Gonzalgo, MD | |
|
1150 Nw 14th St, Miami, FL 33136-2137 | |
| (305) 243-4000 | |
| (305) 243-6597 |
| Full Name | Dr Mark Anthony Lomibao Gonzalgo |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 25 Years |
| Location | 1150 Nw 14th St, Miami, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174570154 | NPI | - | NPPES |
| 406479800 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | D62092 (Maryland) | Secondary |
| 208800000X | Urology | C53670 (California) | Secondary |
| 208800000X | Urology | ME116870 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Miami | 3274795109 | 1781 |
News Archive
The U.S. Food and Drug Administration today approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.
Intensive blood pressure and cholesterol lowering was not associated with reduced risk for diabetes-related cognitive decline in older patients with long-standing type 2 diabetes mellitus, according to a study by Jeff D. Williamson, M.D., M.H.S., of the Wake Forest School of Medicine, Winston-Salem, N.C., and colleagues.
Introgen Therapeutics has announced that a patent with broad claims directed to combination therapy with the p53 gene and conventional chemotherapy or radiation was issued in China.
A team of scientists from the Helmholtz-Zentrum Dresden-Rossendorf, in collaboration with researchers from Monash University Australia, has succeeded in significantly increasing the stability and biocompatibility of special light-transducing nanoparticles.
Bruker announces that it has acquired Luxendo, a privately held spin-off of the European Molecular Biology Laboratory (EMBL) that develops and manufactures proprietary light-sheet fluorescence microscopy instruments.
› Verified 9 days ago
| Entity Name | University Of Miami |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013967827 PECOS PAC ID: 3274795109 Enrollment ID: O20200406001006 |
News Archive
The U.S. Food and Drug Administration today approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.
Intensive blood pressure and cholesterol lowering was not associated with reduced risk for diabetes-related cognitive decline in older patients with long-standing type 2 diabetes mellitus, according to a study by Jeff D. Williamson, M.D., M.H.S., of the Wake Forest School of Medicine, Winston-Salem, N.C., and colleagues.
Introgen Therapeutics has announced that a patent with broad claims directed to combination therapy with the p53 gene and conventional chemotherapy or radiation was issued in China.
A team of scientists from the Helmholtz-Zentrum Dresden-Rossendorf, in collaboration with researchers from Monash University Australia, has succeeded in significantly increasing the stability and biocompatibility of special light-transducing nanoparticles.
Bruker announces that it has acquired Luxendo, a privately held spin-off of the European Molecular Biology Laboratory (EMBL) that develops and manufactures proprietary light-sheet fluorescence microscopy instruments.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Anthony Lomibao Gonzalgo, MD 1150 Nw 14th St, Miami, FL 33136-2137 Ph: (305) 243-4000 | Dr Mark Anthony Lomibao Gonzalgo, MD 1150 Nw 14th St, Miami, FL 33136-2137 Ph: (305) 243-4000 |
News Archive
The U.S. Food and Drug Administration today approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.
Intensive blood pressure and cholesterol lowering was not associated with reduced risk for diabetes-related cognitive decline in older patients with long-standing type 2 diabetes mellitus, according to a study by Jeff D. Williamson, M.D., M.H.S., of the Wake Forest School of Medicine, Winston-Salem, N.C., and colleagues.
Introgen Therapeutics has announced that a patent with broad claims directed to combination therapy with the p53 gene and conventional chemotherapy or radiation was issued in China.
A team of scientists from the Helmholtz-Zentrum Dresden-Rossendorf, in collaboration with researchers from Monash University Australia, has succeeded in significantly increasing the stability and biocompatibility of special light-transducing nanoparticles.
Bruker announces that it has acquired Luxendo, a privately held spin-off of the European Molecular Biology Laboratory (EMBL) that develops and manufactures proprietary light-sheet fluorescence microscopy instruments.
› Verified 9 days ago
Yekutiel Sandman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 7600 Sw 87th Ave, Suite 206, Miami, FL 33173 Phone: 305-275-5525 Fax: 305-275-0662 | |
Miguel Alfredo Castellan, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3200 Sw 60th Ct Ste 104, Miami, FL 33155 Phone: 305-669-6448 Fax: 305-663-8485 | |
Dr. Norman L Block, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1611 Nw 12th Ave, Box 016960 (m851), Miami, FL 33136 Phone: 305-243-6391 Fax: 305-243-8470 | |
Leon Francisco Hirzel Iii, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 330 Sw 27th Ave, Suite 503, Miami, FL 33135 Phone: 305-642-1401 Fax: 305-642-1403 | |
Francis Francesco Petrella, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1120 Nw 14th St Ste 1551, Miami, FL 33136 Phone: 305-243-6260 | |
Andrew S Labbie, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3200 Sw 60th Ct Ste 104, Miami, FL 33155 Phone: 305-669-6448 Fax: 305-663-8485 | |
Pedro Felipe Silva De Freitas, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1150 Nw 14th St Ste 309, Miami, FL 33136 Phone: 305-243-6069 Fax: 305-243-4653 |